Comprehensive legal advice on real estate and public-sector matters
The Real Estate & Public practice is the biggest of its kind in Germany. It provides advice to the entire real estate and construction sector while also handling all issues involving the public sector. In doing so, the practice brings together all the relevant areas of law in a unique way.
In line with client requirements, the practice is divided into three sections:
Advice involving the public sector
The entire project development value chain, including planning and construction
Comprehensive legal advice in connection with real estate as an asset class
Our strength: a comprehensive approach
The advisers at CMS Germany regard Real Estate & Public as an integrated area of law, business and life. This way of looking at things distinguishes us both from the major international commercial law firms and from smaller firms with a narrower focus.
In line with this philosophy, complex matters are resolved by a team comprising specialist lawyers from different (or related) areas of law.
We also provide expert coverage of interdisciplinary fields such as corporate law, financing and tax, state aid, administrative and environmental law, procurement, competition, antitrust and copyright law.
For cross-border projects we assemble international teams in conjunction with our foreign offices, which are led by a designated contact person.
Broad-based expertise for a wide range of clients
We successfully advise national and international market leaders in the real estate sector and construction industry, small and midsize construction companies, property developers, architects, engineers and project managers.
Our references include public corporations, banks and insurance companies, in addition to big-name institutional investors and industrial enterprises. The practice's sector expertise is wide-ranging – from the real estate and construction industry, hotels, financial sector, energy, utilities and waste management operators through telecom service providers, transport and infrastructure companies to the pharmaceutical industry.